ArticleHead and neck pathology2026
Metastatic Cancers to the Oral Cavity: A 42-Year Experience.
Article in Head and neck pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeMetastatic cancers to the oral cavity are rare and often indicate a widespread metastatic disease with an unfavorable prognosis. This study aimed to determine their frequency, demographics, and clinical profiles in Thailand.
methodsPathology records were reviewed from 1983 to 2024 for cases diagnosed with metastatic cancers involving the oral cavity. Demographic, clinical, and radiographic data were collected and analyzed.
resultsOf 4057 oral malignancies, 71 (1.8%) were metastatic cancers. Males accounted for 56.3%, while females accounted for 43.7%. The mean age at diagnosis was 61.1 ± 9.9 years. Nodular swelling (59.2%) was the most common clinical presentation, and 77.5% of patients reported pain. Jawbone metastases were 1.5-fold more common than oral mucosal metastases. Most lesions involved the posterior mandible (28.2%) and showed radiolucency radiographically (77.0%). Gingiva (22.5%) was the most common oral mucosal metastatic site. In 12.7% of cases, the primary lesions were not diagnosed at the time of oral presentation. The most common oral metastatic cancers in males were colorectal cancer, followed by lung cancer. In females, breast cancer was the most frequent primary site, followed by thyroid cancer.
conclusionsThe variable distribution of oral metastases across populations suggests geographic and sex-related disparities in the prevalence of the primary malignancies. Their clinical presentations can vary significantly, posing a diagnostic challenge. This study provides a valuable database for clinicians to consider oral metastases in the differential diagnosis of lesions with painful swelling of oral mucosal tissues or jawbones, particularly in older individuals with a history of cancer.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.